Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34.

Rose AE, Christos PJ, Lackaye D, Shapiro RL, Berman R, Mazumdar M, Kamino H, Osman I, Darvishian F.

Am J Surg Pathol. 2011 Oct;35(10):1441-9. doi: 10.1097/PAS.0b013e31822573f5.

2.

Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma.

Feldmeyer L, Tetzlaff M, Fox P, Nagarajan P, Curry J, Ivan D, Torres Cabala CA, Prieto VG, Aung PP.

Am J Dermatopathol. 2016 Jul;38(7):484-91. doi: 10.1097/DAD.0000000000000453.

PMID:
26675354
3.
4.

Assessment of vascular invasion in gastric cancer: a comparative study.

Gresta LT, Rodrigues-Júnior IA, de Castro LP, Cassali GD, Cabral MM.

World J Gastroenterol. 2013 Jun 28;19(24):3761-9. doi: 10.3748/wjg.v19.i24.3761.

5.

Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.

Storr SJ, Safuan S, Mitra A, Elliott F, Walker C, Vasko MJ, Ho B, Cook M, Mohammed RA, Patel PM, Ellis IO, Newton-Bishop JA, Martin SG.

Mod Pathol. 2012 Apr;25(4):493-504. doi: 10.1038/modpathol.2011.182.

6.

Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder.

Gakis G, Todenhöfer T, Braun M, Fend F, Stenzl A, Perner S.

Scand J Urol. 2015;49(5):382-7. doi: 10.3109/21681805.2015.1040449.

PMID:
25921278
7.
8.

Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma-correlation with histopathologic prognosticators and BRAF status.

Aung PP, Leone D, Feller JK, Yang S, Hernandez M, Yaar R, Singh R, Helm T, Mahalingam M.

Hum Pathol. 2015 Feb;46(2):304-12. doi: 10.1016/j.humpath.2014.11.006.

PMID:
25537974
9.

Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.

Weber SK, Sauerwald A, Pölcher M, Braun M, Debald M, Serce NB, Kuhn W, Brunagel-Walgenbach G, Rudlowski C.

Int J Gynecol Cancer. 2012 Oct;22(8):1442-8.

PMID:
22964524
10.

Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival.

Petersson F, Diwan AH, Ivan D, Gershenwald JE, Johnson MM, Harrell R, Prieto VG.

J Cutan Pathol. 2009 Nov;36(11):1157-63. doi: 10.1111/j.1600-0560.2008.01242.x.

PMID:
19222695
11.

Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.

Petitt M, Allison A, Shimoni T, Uchida T, Raimer S, Kelly B.

J Am Acad Dermatol. 2009 Nov;61(5):819-28. doi: 10.1016/j.jaad.2009.04.026.

PMID:
19836642
12.

[Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].

Martini T, Ströbel P, Steidler A, Petrakopoulou N, Erben P, Bolenz C.

Urologe A. 2015 Jan;54(1):70-5. doi: 10.1007/s00120-014-3646-6. German.

PMID:
25391439
13.
14.

Lymphovascular invasion as a prognostic factor in melanoma.

Egger ME, Gilbert JE, Burton AL, McMasters KM, Callender GG, Quillo AR, Brown RE, St Hill CR, Hagendoorn L, Martin RC 2nd, Stromberg AJ, Scoggins CR.

Am Surg. 2011 Aug;77(8):992-7.

PMID:
21944512
15.

Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication.

Perry C, Soomro I, Kaye P, Hardy E, Parsons SL, Ragunath K, Lobo DN, Martin SG, Madhusudan S.

Dis Esophagus. 2015 Apr;28(3):262-8. doi: 10.1111/dote.12190.

PMID:
24612464
16.

Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer.

Britto AV, Schenka AA, Moraes-Schenka NG, Alvarenga M, Shinzato JY, Vassallo J, Ward LS.

BMC Cancer. 2009 Apr 8;9:109. doi: 10.1186/1471-2407-9-109.

17.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039
18.

Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.

Laser J, Cangiarella J, Singh B, Melamed J, Chiriboga L, Yee H, Darvishian F.

Ann Clin Lab Sci. 2008 Spring;38(2):99-104.

PMID:
18469353
19.

Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma.

Pastushenko I, Vermeulen PB, Vicente-Arregui S, Van den Eynden GG, Alvarez-Alegret R, Querol I, Rutten A, Carapeto FJ, Dirix LY, Van Laere S.

J Cutan Pathol. 2015 Oct;42(10):699-711. doi: 10.1111/cup.12571.

PMID:
26264662
20.

Lymphangiogenic and angiogenic microvessel density in chinese patients with gastric carcinoma: correlation with clinicopathologic parameters and prognosis.

Cao F, Hu YW, Li P, Liu Y, Wang K, Ma L, Li PF, Ni CR, Ding HZ.

Asian Pac J Cancer Prev. 2013;14(8):4549-52.

Supplemental Content

Support Center